
ISB 2001 Earns Orphan Drug Designation for the Treatment of Multiple Myeloma
Orphan Drug designation is granted to therapies that are designed to treat, diagnose, or prevent rare diseases or conditions. In the United States, a rare condition is one affecting fewer…